Image
The NiO digital PCR instrument by Stilla Technologies is now in Greece for the first time!
We are thrilled to announce that, for the first time in Greece, the 7-channel digital PCR system, NiO by Stilla Technologies, has been installed in our laboratory facilities. This state-of-the-art instrument represents a significant leap forward in our capabilities, enabling us to explore new, highly precise approaches in molecular diagnostics. Its installation marks a significant step toward advancing our capabilities in research, product development, and improving diagnostic approaches in cancer.
-
Image
Oncolipsy Sponsorship and Οral Presentation at the 8th Annual Conference on Cancer Biology and New Molecules in Cancer Therapeutics, Athens, Greece
We were proud to participate as sponsors at the 8th Annual Meeting on Cancer Biology and New Molecules in Cancer Therapeutics. During the event, we had the opportunity to showcase our products and present their potential applications in advancing cancer research and therapeutics. It was a great opportunity to connect with oncologists, highlighting the innovative solutions Oncolipsy offers.
-
Image
Clinical Evaluation of Oncolipsy Products: Poster Presentation at IFCC Worldlab 2024, Dubai
As part of our ongoing efforts to advance the clinical evaluation of our products, we proudly participated in the IFCC Worldlab 2024, where we presented the results of studies conducted on liquid biopsy samples from cancer patients in poster presentations. These findings underscore the potential of our Oncolipsy products in enhancing cancer diagnostics, further validating their role in the clinical landscape of liquid biopsy.
-
Image
Poster Presentation at the 7th Hellenic Cancer Conference, Thessaloniki, Greece
During the conference, we had the opportunity to present our posters, showcasing the potential applications of our products in advancing cancer research and treatment. It was a valuable opportunity to connect with clinicians and experts in the oncology field, highlighting the innovative approaches Oncolipsy provides.
-
Image
AACR Annual Meeting 2024, San Diego, California, USA: A great milestone for Oncolipsy products
For the first time, the results of clinical studies using the Oncolipsy products were showcased as posters at the AACR Meeting 2024. We presented the clinical evaluation data of the Oncolipsy PD-L1 and PIK3CA kits highlighting their application in liquid biopsy for cancer patients.
-
Image
6th ACTC 2023: Advances in Circulating Tumor Cells: “Liquid Biopsy and Precision Oncology: Where do we stand now??”, Skiathos, Greece
The Oncolipsy Team was honored to participate as a sponsor at the 6th ACTC Meeting in Skiathos. It was a fantastic opportunity to connect with key opinion leaders, researchers and experts in the liquid biopsy field, engaging in insightful discussions at our booth about the value and applications of Oncolipsy products. Our Oncolipsy PD-L1 and PIK3CA kits were highlighted as some of the most important and innovative advancements in the liquid biopsy industry.
-
Image
3rd Hellenic Biocluster Forum: "Supporting disruptive innovation to maximize the economic and social impact of the bio-industry sector", Athens, Greece
The Oncolipsy Team participated in the 3rd Hellenic Biocluster Forum in Athens as a proud member of the HBio community. The Forum brought together key opinion leaders and stakeholders from the pharmaceutical and biotech sectors. During the event, we had the valuable opportunity to engage with industry leaders, academics, mentors, and life sciences professionals at booth 17, fostering meaningful discussions and connections.
-
Image
Oncolipsy at BIOEUROPE 2022
We are proud to participate in this year's BIOEUROPE 2022 in Leipzig, showcasing our Oncolipsy CE-IVD products. It is our great pleasure to be part of the Hellenic Biocluster (HBio) mission, exhibiting along with members of Greek biotech and pharma sectors, in an inviting booth. The HBio presence in BIOEUROPE 2022 is supported by Enterprise Greece.
We are looking forward to seeing you at our booth #66C and scheduling in-person meetings for potential fruitful collaborations.
-
Image
5th ACTC 2021: Advances in circulating tumor cells "Liquid Biopsy in its best", Kalamata, Greece
Pharmassist Ltd was taking part in the "5th Advances in Circulating Tumor Cells: Liquid Biopsy in its best" (ACTC 2021) meeting in Kalamata, proudly introducing our Oncolipsy liquid biopsy diagnostic kits in the field of oncology. After 6 years of hard work, we were privileged to participate with our very own booth in this prominent conference, along with more than 200 Researchers and KOLs on the liquid biopsy field.
-
Image
The EACR Conference on Liquid Biopsies, Bergamo, Italy
We are excited to start out 2022 by joining the Liquid Biopsies EACR conference in Bergamo.
| Dates | Tuesday, 24 May, 2022 to Thursday, 26 May, 2022 |
| Location | Bergamo, Italy |
| Venue | Viale Papa Giovanni XXIII, 106 |